Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
Current Biology : CB|November 11, 1999
Control of cell growth by c-Myc in the absence of cell divisionM Schuhmacher, M S Staege, A Pajic, et al.International Journal of Cancer|August 24, 2001
Antagonistic effects of c-myc and Epstein-Barr virus latent genes on the phenotype of human B cellsA Pajic, M S Staege, D Dudziak, et al.Gene Therapy|February 1, 1997
Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cellsS Mũcke, A Polack, M Pawlita, et al.Gene|March 1, 1984
A complete set of overlapping cosmid clones of M-ABA virus derived from nasopharyngeal carcinoma and its similarity to other Epstein-Barr virus isolatesA Polack, G Hartl, U Zimber, et al.Proceedings of the National Academy of Sciences of the United States of America|September 17, 1996
c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1A Polack, K Hörtnagel, A Pajic, et al.Biomaterials|February 14, 2004
Materials design in the performance of all-ceramic crownsBrian R Lawn, Antonia Pajares, Yu Zhang, et al.International Journal of Cancer|April 13, 2000
Suppression of the tumorigenic growth of Burkitt's lymphoma cells in immunodeficient mice by cytokine gene transfer using EBV-derived episomal expression vectorsS Mücke, A Draube, A Polack, et al.Blood|March 9, 2000
Inducible loss of NF-kappaB activity is associated with apoptosis and Bcl-2 down-regulation in Epstein-Barr virus-transformed B lymphocytesJ Feuillard, M Schuhmacher, S Kohanna, et al.IARC Scientific Publications|January 1, 1991
Epstein-Barr virus activators, mutagens and volatile nitrosamines in preserved food samples from high-risk areas for nasopharyngeal carcinomaG Bouvier, S Poirier, Y M Shao, et al.Nucleic Acids Research|January 5, 2001
The transcriptional program of a human B cell line in response to MycM Schuhmacher, F Kohlhuber, M Hölzel, et al.Pageof 7